Structural investigation of the 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione scaffold to obtain AMPA and kainate receptor selective antagonists.: Synthesis, pharmacological, and molecular modeling studies

被引:51
作者
Colotta, Vittoria
Catarzi, Daniela
Varano, Flavia
Lenzi, Ombretta
Filacchioni, Guido
Costagli, Chiara
Galli, Alessandro
Ghelardini, Carla
Galeotti, Nicoletta
Gratteri, Paola
Sgrignani, Jacopo
Deflorian, Francesca
Moro, Stefano
机构
[1] Univ Florence, Dipartimento Sci Farmaceut, Lab Progettaz Sintesi & Studio Eterocicli Biol At, Lab Mol Modeling Cheminformat & QSAR, I-50019 Sesto Fiorentino, FI, Italy
[2] Univ Florence, Dipartimento Farmacol Preclin & Clin, I-50134 Florence, Italy
[3] Univ Padua, Mol Modeling Sect, Dipartimento Sci Farmaceut, I-35131 Padua, Italy
关键词
D O I
10.1021/jm0604880
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this paper, the study of new 7-chloro-3-hydroxy-1H-quinazoline-2,4-dione derivatives, designed as AMPA and kainate (KA) receptor antagonists, is reported. Some derivatives bear different carboxy-containing alkyl chains on the 3-hydroxy group, while various heterocyclic rings or amide moieties are present at the 6-position of other compounds. Binding data at Gly/NMDA, AMPA, and high-affinity KA receptors showed that the presence of the free 3-hydroxy group is of paramount importance for a good affinity at all three investigated receptors, while introduction of some 6-heterocyclic moieties yielded AMPA-selective antagonists. The most significant result was the finding of the 6-(2-carboxybenzoylamino)-3-hydroxy-1H-quinazolin-2,4dione 12, which possesses good affinity for high-affinity and low-affinity KA receptors (K-i = 0.62 mu M and 1.6 mu M, respectively), as well as good selectivity. To rationalize the trend of affinities of the reported derivatives, an intensive molecular modeling study was carried out by docking compounds to models of the Gly/NMDA, AMPA, and KA receptors.
引用
收藏
页码:6015 / 6026
页数:12
相关论文
共 67 条
[41]   Inhibitors of AMPA and kainate receptors [J].
Madsen, U ;
Stensbol, TB ;
Krogsgaard-Larsen, P .
CURRENT MEDICINAL CHEMISTRY, 2001, 8 (11) :1291-1301
[42]   Pharmacological characterization of metabotropic glutamate receptors potentiating NMDA responses in mouse cortical wedge preparations [J].
Mannaioni, G ;
Carla, V ;
Moroni, F .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (06) :1530-1536
[43]   Crystal structures of the GluR5 and GluR6 ligand binding cores: Molecular mechanisms underlying kainate receptor selectivity [J].
Mayer, ML .
NEURON, 2005, 45 (04) :539-552
[44]   Characterisation of UBP296: a novel, potent and selective kainate receptor antagonist [J].
More, JCA ;
Nistico, R ;
Dolman, NP ;
Clarke, VRJ ;
Alt, AJ ;
Ogden, AM ;
Buelens, FP ;
Troop, HM ;
Kelland, EE ;
Pilato, F ;
Bleakman, D ;
Bortolotto, ZA ;
Collingridge, GL ;
Jane, DE .
NEUROPHARMACOLOGY, 2004, 47 (01) :46-64
[45]   1,3-disubstituted benzazepines as novel, potent, selective neuropeptide YY1 receptor antagonists [J].
Murakami, Y ;
Hara, H ;
Okada, T ;
Hashizume, H ;
Kii, M ;
Ishihara, Y ;
Ishikawa, M ;
Shimamura, M ;
Mihara, S ;
Kato, G ;
Hanasaki, K ;
Hagishita, S ;
Fujimoto, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (14) :2621-2632
[46]   FOLATE ANALOGS .22. SYNTHESIS AND BIOLOGICAL EVALUATION OF 2 ANALOGS OF DIHYDROFOLIC ACID POSSESSING A 7,8-DIHYDRO-8-OXAPTERIN RING-SYSTEM [J].
NAIR, MG ;
SALTER, OC ;
KISLIUK, RL ;
GAUMONT, Y ;
NORTH, G .
JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (08) :1164-1168
[47]   Crystal structure of the kainate receptor GluR5 ligand-binding core in complex with (S)-glutamate [J].
Naur, P ;
Vestergaard, B ;
Skov, LK ;
Egebjerg, J ;
Gajhede, M ;
Kastrup, JS .
FEBS LETTERS, 2005, 579 (05) :1154-1160
[48]  
NIELSEN EO, 1986, EUR J MED CHEM, V21, P433
[49]  
Nielsen EO, 1999, J PHARMACOL EXP THER, V289, P1492
[50]   The role of N-methyl-D-aspartate (NMDA) receptors in pain:: A review [J].
Petrenko, AB ;
Yamakura, T ;
Baba, A ;
Shimoji, K .
ANESTHESIA AND ANALGESIA, 2003, 97 (04) :1108-1116